Kopran Ltd. — Investor Relations & Filings
Kopran Ltd. is an integrated organization specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms. The company maintains a significant focus on semi-synthetic penicillins and cephalosporins, alongside a diverse portfolio covering therapeutic areas such as cardiovascular health, diabetes management, and anti-infectives. Operating through advanced manufacturing facilities that adhere to international quality benchmarks, the entity provides a vertically integrated supply chain. Its core activities encompass chemical synthesis and the production of oral solids and dry powder injectables. With a dedicated emphasis on research and development, the company serves a global clientele, focusing on high-quality medicinal solutions and process optimization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Shareholders meeting | 2026-05-07 | English | |
| Copy of Newspaper Publication | 2026-05-04 | English | |
| Shareholders meeting | 2026-04-30 | English | |
| Amalgamation/Merger | 2026-04-30 | English | |
| Disclosure under SEBI Takeover Regulations | 2026-04-10 | English | |
| Disclosure under SEBI Takeover Regulations | 2026-04-10 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42816666 | Shareholders meeting | 2026-05-07 | English | ||
| 42203617 | Copy of Newspaper Publication | 2026-05-04 | English | ||
| 42167287 | Shareholders meeting | 2026-04-30 | English | ||
| 42167842 | Amalgamation/Merger | 2026-04-30 | English | ||
| 42201116 | Disclosure under SEBI Takeover Regulations | 2026-04-10 | English | ||
| 42201136 | Disclosure under SEBI Takeover Regulations | 2026-04-10 | English | ||
| 42202524 | Amalgamation/Merger | 2026-04-10 | English | ||
| 42206480 | Price movement | 2026-04-10 | English | ||
| 42169307 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-09 | English | ||
| 42187566 | Spurt in Volume | 2026-04-08 | English | ||
| 42202046 | Trading Window | 2026-03-24 | English | ||
| 42180261 | Resignation | 2026-03-17 | English | ||
| 42190350 | Amalgamation/Merger | 2026-02-28 | English | ||
| 42195491 | Amalgamation/Merger | 2026-02-27 | English | ||
| 42199797 | General Updates | 2026-02-20 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Bicara Therapeutics Inc.
Clinical-stage biopharma developing dual-action biologics f…
|
BCAX | US | Manufacturing |
|
BICYCLE THERAPEUTICS PLC
Clinical-stage biopharma developing a novel class of bicycl…
|
BCYC | GB | Manufacturing |
|
BIFIDO. Co. Ltd
Biotechnology firm developing human-derived Bifidobacterium…
|
238200 | KR | Manufacturing |
|
Binex Co., Ltd.
Biopharmaceutical firm with pharma manufacturing and biolog…
|
053030 | KR | Manufacturing |
|
BioAge Labs, Inc.
A clinical-stage biotech developing therapies for metabolic…
|
BIOA | US | Manufacturing |
|
Bioasis Technologies Inc.
Developing the xB3 platform to deliver therapeutics across …
|
BIOAF | CA | Manufacturing |
|
BioAtla, Inc.
Develops antibody-based therapeutics activated within the t…
|
BCAB | US | Manufacturing |
|
BIOBIJOU Co., Ltd.
Develops and manufactures medical aesthetic products like H…
|
489460 | KR | Manufacturing |
|
BioCardia, Inc.
Develops cell-derived therapeutics for cardiovascular and p…
|
BCDA | US | Manufacturing |
|
Biocartis Group NV
Develops and commercializes an automated molecular diagnost…
|
BCART | BE | Manufacturing |
Kopran Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/59386/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=59386 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=59386 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=59386 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 59386}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Kopran Ltd. (id: 59386)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.